研究・業績

2020年

  1. Yoshikawa S, Yoshio S, Yoshida Y, Tsutsui Y, Kawai H, Yamazoe T, Mori T, Osawa Y, Sugiyama M, Iwamoto M, Watashi K, Kawaguchi T, Akita T, Tanaka J, Kikuchi Y, Mizokami M, Oka S, Kanto T, Gatanaga H.
    Impact of Immune Reconstitution-induced Hepatic Flare on HBsAg Loss in HBV/HIV-1-Coinfected Patients. J Infect Dis. 2020 Oct 19:jiaa662. doi: 10.1093/infdis/jiaa662.
    内容紹介

  2. Yamazoe T, Mori T, Yoshio S, Kanto T
    Hepatocyte ploidy and pathological mutations in hepatocellular carcinoma: impact on oncogenesis and therapeutics Global Health & Medicine. 2020; 2(5):273-281. doi: 10.35772/ghm.2020.01089

共著論文

  1. Fukushima K, Satoh T, Sugihara F, Sato Y, Okamoto T, Mitsui Y, Yoshio S, Li S, Nojima S, Motooka D, Nakamura S, Kida H, Standley DM, Morii E, Kanto T, Yanagita M, Matsuura Y, Nagasawa T, Kumanogoh A, Akira S.
    Dysregulated Expression of the Nuclear Exosome Targeting Complex Component Rbm7 in Nonhematopoietic Cells Licenses the Development of Fibrosis. Immunity. 2020 Mar 17;52(3):542-556.e13. doi: 10.1016/j.immuni.2020.02.007.

  2. Kawaguchi T, Yoshio S, Sakamoto Y, Hashida R, Koya S, Hirota K, Nakano D, Yamamura S, Niizeki T, Matsuse H, Torimura T.
    Impact of Decorin on the Physical Function and Prognosis of Patients with Hepatocellular Carcinoma. J Clin Med. 2020 Mar 28;9(4):936. doi: 10.3390/jcm9040936.

  3. Komatsu H, Inui A, Yoshio S, Fujisawa T.
    Pharmacotherapy options for managing hepatitis B in children. Expert Opin Pharmacother. 2020 Oct 22. doi: 10.1080/14656566.2020.1841165. Online ahead of print.

国立国際医療研究センター
肝炎・免疫研究センター
肝疾患研究部

〒272-8516 千葉県市川市国府台1-7-1
TEL 047-372-3501/FAX 047-375-4766